ElitePhysiqMD review

ElitePhysiqMD makes individual product prices visible, but the medicine figure needs a second look. Sermorelin is $292.50 monthly on member refill; membership costs $39 to activate and then $89 a month. A one-time order is $404: $325 medicine, a $49 visit and $30 shipping. Member visits are advertised at $0 while the product also says a $49 visit is required, so the first charge needs confirmation. Its named medical director and live video assessment offer clearer accountability; the assigned pharmacy remains unnamed.

ElitePhysiqMD Group Inc. operates a telehealth storefront for peptides, hormone therapy, GLP-1 weight management, ED care, hair care and supplements. It names Hridayesh Nat, MD, as medical director and shows a broad peptide list, including sermorelin, CJC-1295/ipamorelin, BPC-157, tesamorelin, glutathione, GHK-Cu, NAD⁺, MOTS-C and PT-141. An eighteen-product headline does not consistently describe the broader list. Monthly and every-three-month selectors are product-specific; epithalon is priced every three months for a product titled a ten-day cycle. It claims LegitScript certification, 503A/503B sourcing, fifty-state service and HSA/FSA eligibility. Qualiphy branding identifies a platform or network connection, not the dispensing pharmacy.

A product choice and online assessment lead to a live video physician visit, with prescribing only if appropriate. Products say medication is not charged if declined, which does not promise a refund of every service fee. No individual dispensing pharmacy is named. The hormone program describes panel testing and possible use of recent results; its testosterone page describes baseline and follow-up labs. That service description does not establish actual monitoring performance. For growth-hormone-axis peptides, a baseline panel is not described as part of the default path. Shipping promises differ: the homepage gives two to three business days to ship and two to five to receive, versus program twenty-four-hour shipping and member overnight cold-pack claims. Membership renews automatically until canceled. Account pause or cancellation and no cancellation penalty are advertised, but terms make transactions nonrefundable, deny partial membership credits and retain access through the paid term; the processing deadline is unclear. Web terms require adults, while platform terms allow guardian-consented use under 18, without establishing pediatric product access. Privacy describes commerce-chat data and health-information handling. The public HIPAA and consent notices do not provide substantive terms to assess their compliance claims.

Monthly member medicine prices are sermorelin $292.50, NAD⁺ $350.10, CJC-1295/ipamorelin $315 and glutathione $260.10. Membership is separate: $39 activation, then $89 monthly. Medicine plus recurring membership would be $381.50 for sermorelin or $439.10 for NAD⁺, before resolving the product’s required $49 visit versus advertised $0 member visits; those sums are not confirmed first charges. One-time sermorelin is $325 medicine plus $49 visit and $30 shipping, totaling $404; NAD⁺ is $389 plus those fees, totaling $468. Three-month sermorelin is $665.10 every three months plus membership, or $739 medicine and $818 total one-time. These labels do not establish vial count or concentration. Other monthly member figures are BPC-157 $169.20, BPC-157/TB-500 $254.70, tesamorelin $268.20, tesamorelin/ipamorelin $315, GHK-Cu $292.50, MOTS-C $400.50, thymosin $236.70, kisspeptin $146.70 and PT-141 $260.10. Epithalon is $146.70 every three months for a ten-day-cycle product, not a monthly price. Testosterone is $175.50 member/$195 one-time medicine; enclomiphene $296.10/$329 and HCG $200.70/$223, before applicable membership or visit/shipping fees. Homepage $161 and program $215 starting headlines differ from individual listings. Confirm the selected product, first debit and cancellation timing; no-insurance and HSA/FSA use are advertised.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. ElitePhysiqMD states its medications come from state-licensed 503A and 503B compounding pharmacies registered with FDA, which is a clearer sourcing description than many telehealth platforms give, but it names no individual pharmacy — and compounded sterile products are not reviewed by FDA for purity and potency the way approved drugs are. On the evidence, a price list does not tell you which products work, and the products on this one differ widely. Sermorelin, CJC-1295/ipamorelin and tesamorelin act on the growth-hormone axis, a real and well-described mechanism; tesamorelin is the one with genuine approved human evidence, and that evidence is for HIV-associated lipodystrophy specifically, not the body-composition and anti-aging outcomes the category is marketed on, and the compounded version sold here is not the approved product. For sermorelin and CJC-1295/ipamorelin, long-term human outcome data stays thin. BPC-157, GHK-Cu and injectable glutathione sit lower again, with essentially no controlled human outcome trials for the healing, skin and recovery claims attached to them. NAD⁺ by injection has no controlled outcome trials either; the studied forms are the oral precursors NR and NMN, which raise blood NAD⁺ rather than demonstrating a clinical benefit. PT-141 is the outlier in the other direction — bremelanotide has been through registrational human trials for hypoactive sexual desire disorder in premenopausal women. Individual results vary.